Literature DB >> 15742474

Novel c-KIT germline mutation in a family with gastrointestinal stromal tumors and cutaneous hyperpigmentation.

Miguel Carballo1, Ignasi Roig, Francesc Aguilar, Maria Antonia Pol, María José Gamundi, Imma Hernan, María Martinez-Gimeno.   

Abstract

Mutations in the c-KIT gene have been identified in many sporadic and familial cases of gastrointestinal stromal tumor (GIST). We report a familial case of GIST with cutaneous hyperpigmentation associated with a novel germline mutation in the c-KIT gene. Screening for mutations in exon 11 of the c-KIT gene in genomic DNA from tumors and peripheral blood of the members of a family with GISTs was undertaken by direct genomic sequencing. Tumors from GIST patients were analyzed histologically and immunohistochemically. Clinical examination of GIST patients was also performed to detect other systemic diseases associated with c-KIT mutations. Histological study showed that the tumors were GISTs expressing CD34 and c-KIT protein. This GIST-hyperpigmentation disease was associated in the family with a germline mutation in the c-KIT gene. The mutation is a duplication of the sequence CAACTT located in exon 11 of the c-KIT gene, which introduces two extra glutamine and leucine residues in the encoding protein between positions 576 and 577. This Spanish family was affected with GISTs and cutaneous hyperpigmentation associated with a novel germline mutation Leu576_Pro577insGlnLeu in the juxtamembrane domain of the c-KIT receptor. These types of mutation in the c-KIT gene activate the tyrosine kinase activity of the c-KIT receptor and induce constitutive signaling leading to GISTs, in some cases associated with cutaneous hyperpigmentation. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15742474     DOI: 10.1002/ajmg.a.30388

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

Review 1.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

Review 2.  Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.

Authors:  S Farag; L E van der Kolk; H H van Boven; A C J van Akkooi; G L Beets; J W Wilmink; N Steeghs
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

Review 3.  Gastrointestinal stromal tumors.

Authors:  Maureen J O'Sullivan
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

4.  Characterization of various types of mast cells derived from model mice of familial gastrointestinal stromal tumors with KIT-Asp818Tyr mutation.

Authors:  Noriko Kajimoto; Norihiro Nakai; Mizuka Ohkouchi; Yuka Hashikura; Ning-Ning Liu-Kimura; Koji Isozaki; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Gain-of-Function Mutations of Receptor Tyrosine Kinases in Gastrointestinal Stromal Tumors.

Authors:  K Isozaki; S Hirota
Journal:  Curr Genomics       Date:  2006       Impact factor: 2.236

Review 6.  Gastrointestinal stromal tumor: a bridge between bench and bedside.

Authors:  Toshirou Nishida; Tsuyoshi Takahashi; Yasuaki Miyazaki
Journal:  Gastric Cancer       Date:  2010-01-05       Impact factor: 7.370

7.  Optimizing imatinib mesylate treatment in gastrointestinal stromal tumors.

Authors:  Yixing Jiang; Lee Ming; Alberto J Montero; Eric Kimchi; Mehrdad Nikfarjam; Kevin F Staveley-O'Carroll
Journal:  Gastrointest Cancer Res       Date:  2008-09

Review 8.  Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors.

Authors:  Yasuhisa Shinomura; Kazuo Kinoshita; Shusaku Tsutsui; Seiichi Hirota
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 6.772

9.  Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications.

Authors:  Michael A Postow; Mark E Robson
Journal:  Clin Sarcoma Res       Date:  2012-10-04

10.  Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors.

Authors:  Jean-Baptiste Bachet; Jean-François Emile
Journal:  Appl Clin Genet       Date:  2010-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.